Pepřovník opojný (Czech Wikipedia)

Analysis of information sources in references of the Wikipedia article "Pepřovník opojný" in Czech language version.

refsWebsite
Global rank Czech rank
4th place
8th place
5th place
3rd place
2nd place
4th place
low place
low place
3,733rd place
1,015th place
low place
low place
low place
low place
low place
low place
222nd place
83rd place

doi.org

dx.doi.org

  • SOARES, Rita B.; DINIS-OLIVEIRA, Ricardo Jorge; OLIVEIRA, Nuno G. An Updated Review on the Psychoactive, Toxic and Anticancer Properties of Kava. Journal of Clinical Medicine. 2022-07-12, roč. 11, čís. 14, s. 4039. PMID: 35887801 PMCID: PMC9315573. Dostupné online [cit. 2024-02-23]. ISSN 2077-0383. DOI 10.3390/jcm11144039. PMID 35887801. 
  • SARRIS, Jerome; STOUGH, Con; BOUSMAN, Chad A. Kava in the treatment of generalized anxiety disorder: a double-blind, randomized, placebo-controlled study. Journal of Clinical Psychopharmacology. 2013-10, roč. 33, čís. 5, s. 643–648. PMID: 23635869. Dostupné online [cit. 2024-02-23]. ISSN 1533-712X. DOI 10.1097/JCP.0b013e318291be67. PMID 23635869. 
  • SARRIS, Jerome; STOUGH, Con; BOUSMAN, Chad A. Kava in the treatment of generalized anxiety disorder: a double-blind, randomized, placebo-controlled study. Journal of Clinical Psychopharmacology. 2013-10, roč. 33, čís. 5, s. 643–648. PMID: 23635869. Dostupné online [cit. 2024-02-23]. ISSN 1533-712X. DOI 10.1097/JCP.0b013e318291be67. PMID 23635869. 
  • GURLEY, Bill J.; GARDNER, Stephanie F.; HUBBARD, Martha A. In Vivo Effects of Goldenseal, Kava Kava, Black Cohosh, and Valerian on Human Cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 Phenotypes. Clinical Pharmacology & Therapeutics. 2005, roč. 77, čís. 5, s. 415–426. Dostupné online [cit. 2024-12-01]. ISSN 1532-6535. DOI 10.1016/j.clpt.2005.01.009. PMID 15900287. (anglicky) 
  • MESEGUER, Elena; TABOADA, Rocio; SÁNCHEZ, Vicenta. Life-threatening parkinsonism induced by kava-kava. Movement Disorders: Official Journal of the Movement Disorder Society. 2002-01, roč. 17, čís. 1, s. 195–196. PMID: 11835463. Dostupné online [cit. 2024-02-23]. ISSN 0885-3185. DOI 10.1002/mds.1268. PMID 11835463. 

drinkroot.com

  • DRINKROOT. Kava Dosage: How much kava should I take?. drinkroot [online]. [cit. 2024-02-23]. Dostupné online. (anglicky) 

healthline.com

  • Kava Kava: Benefits, Side Effects and Dosage. Healthline [online]. 2018-02-10 [cit. 2024-02-23]. Dostupné online. (anglicky) 

kavasociety.nz

  • Kava and Caffeine. The Kava Society [online]. [cit. 2024-09-04]. Dostupné online. (anglicky) 

nih.gov

ncbi.nlm.nih.gov

  • SOARES, Rita B.; DINIS-OLIVEIRA, Ricardo Jorge; OLIVEIRA, Nuno G. An Updated Review on the Psychoactive, Toxic and Anticancer Properties of Kava. Journal of Clinical Medicine. 2022-07-12, roč. 11, čís. 14, s. 4039. PMID: 35887801 PMCID: PMC9315573. Dostupné online [cit. 2024-02-23]. ISSN 2077-0383. DOI 10.3390/jcm11144039. PMID 35887801. 
  • SARRIS, Jerome; STOUGH, Con; BOUSMAN, Chad A. Kava in the treatment of generalized anxiety disorder: a double-blind, randomized, placebo-controlled study. Journal of Clinical Psychopharmacology. 2013-10, roč. 33, čís. 5, s. 643–648. PMID: 23635869. Dostupné online [cit. 2024-02-23]. ISSN 1533-712X. DOI 10.1097/JCP.0b013e318291be67. PMID 23635869. 
  • SARRIS, Jerome; STOUGH, Con; BOUSMAN, Chad A. Kava in the treatment of generalized anxiety disorder: a double-blind, randomized, placebo-controlled study. Journal of Clinical Psychopharmacology. 2013-10, roč. 33, čís. 5, s. 643–648. PMID: 23635869. Dostupné online [cit. 2024-02-23]. ISSN 1533-712X. DOI 10.1097/JCP.0b013e318291be67. PMID 23635869. 
  • GURLEY, Bill J.; GARDNER, Stephanie F.; HUBBARD, Martha A. In Vivo Effects of Goldenseal, Kava Kava, Black Cohosh, and Valerian on Human Cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 Phenotypes. Clinical Pharmacology & Therapeutics. 2005, roč. 77, čís. 5, s. 415–426. Dostupné online [cit. 2024-12-01]. ISSN 1532-6535. DOI 10.1016/j.clpt.2005.01.009. PMID 15900287. (anglicky) 
  • MESEGUER, Elena; TABOADA, Rocio; SÁNCHEZ, Vicenta. Life-threatening parkinsonism induced by kava-kava. Movement Disorders: Official Journal of the Movement Disorder Society. 2002-01, roč. 17, čís. 1, s. 195–196. PMID: 11835463. Dostupné online [cit. 2024-02-23]. ISSN 0885-3185. DOI 10.1002/mds.1268. PMID 11835463. 

pubmed.ncbi.nlm.nih.gov

  • SARRIS, Jerome; STOUGH, Con; BOUSMAN, Chad A. Kava in the treatment of generalized anxiety disorder: a double-blind, randomized, placebo-controlled study. Journal of Clinical Psychopharmacology. 2013-10, roč. 33, čís. 5, s. 643–648. PMID: 23635869. Dostupné online [cit. 2024-02-23]. ISSN 1533-712X. DOI 10.1097/JCP.0b013e318291be67. PMID 23635869. 
  • SARRIS, Jerome; STOUGH, Con; BOUSMAN, Chad A. Kava in the treatment of generalized anxiety disorder: a double-blind, randomized, placebo-controlled study. Journal of Clinical Psychopharmacology. 2013-10, roč. 33, čís. 5, s. 643–648. PMID: 23635869. Dostupné online [cit. 2024-02-23]. ISSN 1533-712X. DOI 10.1097/JCP.0b013e318291be67. PMID 23635869. 
  • MESEGUER, Elena; TABOADA, Rocio; SÁNCHEZ, Vicenta. Life-threatening parkinsonism induced by kava-kava. Movement Disorders: Official Journal of the Movement Disorder Society. 2002-01, roč. 17, čís. 1, s. 195–196. PMID: 11835463. Dostupné online [cit. 2024-02-23]. ISSN 0885-3185. DOI 10.1002/mds.1268. PMID 11835463. 

restorativemedicine.org

  • Kava Kava (Piper methysticum) [online]. [cit. 2024-08-11]. Dostupné online. (anglicky) 

transparentlabs.com

  • Beginner's Kava Kava Guide: Benefits, Risks, & Dosing. Transparent Labs [online]. [cit. 2024-02-23]. Dostupné online. (anglicky) 

wiley.com

ascpt.onlinelibrary.wiley.com

  • GURLEY, Bill J.; GARDNER, Stephanie F.; HUBBARD, Martha A. In Vivo Effects of Goldenseal, Kava Kava, Black Cohosh, and Valerian on Human Cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 Phenotypes. Clinical Pharmacology & Therapeutics. 2005, roč. 77, čís. 5, s. 415–426. Dostupné online [cit. 2024-12-01]. ISSN 1532-6535. DOI 10.1016/j.clpt.2005.01.009. PMID 15900287. (anglicky) 

worldcat.org

  • SOARES, Rita B.; DINIS-OLIVEIRA, Ricardo Jorge; OLIVEIRA, Nuno G. An Updated Review on the Psychoactive, Toxic and Anticancer Properties of Kava. Journal of Clinical Medicine. 2022-07-12, roč. 11, čís. 14, s. 4039. PMID: 35887801 PMCID: PMC9315573. Dostupné online [cit. 2024-02-23]. ISSN 2077-0383. DOI 10.3390/jcm11144039. PMID 35887801. 
  • SARRIS, Jerome; STOUGH, Con; BOUSMAN, Chad A. Kava in the treatment of generalized anxiety disorder: a double-blind, randomized, placebo-controlled study. Journal of Clinical Psychopharmacology. 2013-10, roč. 33, čís. 5, s. 643–648. PMID: 23635869. Dostupné online [cit. 2024-02-23]. ISSN 1533-712X. DOI 10.1097/JCP.0b013e318291be67. PMID 23635869. 
  • SARRIS, Jerome; STOUGH, Con; BOUSMAN, Chad A. Kava in the treatment of generalized anxiety disorder: a double-blind, randomized, placebo-controlled study. Journal of Clinical Psychopharmacology. 2013-10, roč. 33, čís. 5, s. 643–648. PMID: 23635869. Dostupné online [cit. 2024-02-23]. ISSN 1533-712X. DOI 10.1097/JCP.0b013e318291be67. PMID 23635869. 
  • GURLEY, Bill J.; GARDNER, Stephanie F.; HUBBARD, Martha A. In Vivo Effects of Goldenseal, Kava Kava, Black Cohosh, and Valerian on Human Cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 Phenotypes. Clinical Pharmacology & Therapeutics. 2005, roč. 77, čís. 5, s. 415–426. Dostupné online [cit. 2024-12-01]. ISSN 1532-6535. DOI 10.1016/j.clpt.2005.01.009. PMID 15900287. (anglicky) 
  • MESEGUER, Elena; TABOADA, Rocio; SÁNCHEZ, Vicenta. Life-threatening parkinsonism induced by kava-kava. Movement Disorders: Official Journal of the Movement Disorder Society. 2002-01, roč. 17, čís. 1, s. 195–196. PMID: 11835463. Dostupné online [cit. 2024-02-23]. ISSN 0885-3185. DOI 10.1002/mds.1268. PMID 11835463.